review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1032027318 |
P356 | DOI | 10.1186/BCR1286 |
P932 | PMC publication ID | 1242144 |
P698 | PubMed publication ID | 16168137 |
P5875 | ResearchGate publication ID | 7595860 |
P50 | author | Mina Bissell | Q4794835 |
Jamie L Inman | Q125194207 | ||
Melissa C Adriance | Q125194465 | ||
P2093 | author name string | Ole W Petersen | |
P2860 | cites work | Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development | Q70953052 |
Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene | Q72864223 | ||
Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma | Q72954560 | ||
Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases | Q72957208 | ||
Cellular distribution of the angiogenic factor heparin affin regulatory peptide (HARP) mRNA and protein in the human mammary gland | Q73665845 | ||
Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells | Q74392346 | ||
Human mammary luminal epithelial cells contain progenitors to myoepithelial cells | Q77905596 | ||
Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells | Q21195157 | ||
Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation | Q22008650 | ||
Form and function: the laminin family of heterotrimers | Q22254277 | ||
Involvement of chemokine receptors in breast cancer metastasis | Q24290909 | ||
Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells | Q24336533 | ||
Stromal effects on mammary gland development and breast cancer | Q24645558 | ||
Epimorphin functions as a key morphoregulator for mammary epithelial cells | Q24683620 | ||
Polarity determination in breast tissue: desmosomal adhesion, myoepithelial cells, and laminin 1 | Q24795727 | ||
The mammary myoepithelial cell--Cinderella or ugly sister? | Q24801073 | ||
Molecular portraits of human breast tumours | Q28032461 | ||
Putting tumours in context | Q28207789 | ||
Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells | Q28279929 | ||
Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis | Q28280766 | ||
HGF/SF: a potent cytokine for mammary growth, morphogenesis and development | Q28289006 | ||
CXCR4 regulates growth of both primary and metastatic breast cancer | Q28296113 | ||
Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer | Q28308017 | ||
Laminin alpha1 globular domains 4-5 induce fetal development but are not vital for embryonic basement membrane assembly | Q28586446 | ||
Compositional and structural requirements for laminin and basement membranes during mouse embryo implantation and gastrulation | Q28588876 | ||
The molecular biology of axon guidance | Q29617857 | ||
Molecular characterization of the tumor microenvironment in breast cancer | Q31095898 | ||
Expression and biological role of laminin-1 | Q31140502 | ||
Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition | Q33843987 | ||
Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity | Q33845898 | ||
The mammary gland: a unique organ for the study of development and tumorigenesis | Q33962692 | ||
A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. | Q33962881 | ||
Laminin mediates tissue-specific gene expression in mammary epithelia | Q34058782 | ||
Myoepithelial cell differentiation in rat mammary glands | Q34106306 | ||
Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. | Q34167993 | ||
Netrin-1/neogenin interaction stabilizes multipotent progenitor cap cells during mammary gland morphogenesis | Q34183568 | ||
Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells | Q34792452 | ||
The role of laminin in embryonic cell polarization and tissue organization | Q35123983 | ||
How to make tubes: signaling by the Met receptor tyrosine kinase | Q35147372 | ||
Expression of ATM, p53, and the MRE11-Rad50-NBS1 complex in myoepithelial cells from benign and malignant proliferations of the breast | Q35588096 | ||
Expression of hemidesmosomes and component proteins is lost by invasive breast cancer cells. | Q35796514 | ||
Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules | Q35831087 | ||
Laminin functions in tissue morphogenesis. | Q35912792 | ||
The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis | Q35941939 | ||
Expression genetics in cancer: shifting the focus from DNA to RNA. | Q35966800 | ||
Changes in expression of alpha 6/beta 4 integrin heterodimer in primary and metastatic breast cancer | Q35994154 | ||
Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue | Q36085371 | ||
Cell contacts in the mouse mammary gland. I. Normal gland in postnatal development and the secretory cycle | Q36194942 | ||
Intermediate-sized filaments of the prekeratin type in myoepithelial cells | Q36201230 | ||
A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation | Q36216808 | ||
A function for filamentous alpha-smooth muscle actin: retardation of motility in fibroblasts | Q36237175 | ||
Precocious mammary gland development in P-cadherin-deficient mice. | Q36274361 | ||
Epimorphin mediates mammary luminal morphogenesis through control of C/EBPbeta | Q36366027 | ||
Antibodies against domain E3 of laminin-1 and integrin alpha 6 subunit perturb branching epithelial morphogenesis of submandibular gland, but by different modes | Q36382529 | ||
Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor | Q36443609 | ||
Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties | Q36546865 | ||
Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth | Q36707601 | ||
Division of labor among the alpha6beta4 integrin, beta1 integrins, and an E3 laminin receptor to signal morphogenesis and beta-casein expression in mammary epithelial cells | Q36906768 | ||
Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. | Q37221221 | ||
Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells | Q37264167 | ||
The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. | Q37448181 | ||
beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium | Q37460431 | ||
Monoclonal antibody that defines human myoepithelium | Q37554082 | ||
Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells | Q37722844 | ||
A Paracrine Role for Myoepithelial Cell-Derived FGF2 in the Normal Human Breast | Q38344346 | ||
The myothelia (myoepithelial cells). Normal state; regressive changes; hyperplasia; tumors | Q39893414 | ||
Extracellular matrix components in intestinal development | Q40412676 | ||
Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast | Q40488172 | ||
Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. | Q40612563 | ||
Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype | Q40652942 | ||
Rac1 orientates epithelial apical polarity through effects on basolateral laminin assembly | Q40782515 | ||
Desmosomal adhesion regulates epithelial morphogenesis and cell positioning | Q40782521 | ||
The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype | Q40865269 | ||
The induction of smooth muscle alpha actin in a transformed rat cell line suppresses malignant properties in vitro and in vivo | Q40933085 | ||
Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction | Q40964604 | ||
Growth factors and their receptors in neoplastic mammary glands | Q41068890 | ||
Cell size and shape changes in the myoepithelium of the mammary gland during differentiation | Q41345957 | ||
Monoclonal antibodies against laminin A chain fragment E3 and their effects on binding to cells and proteoglycan and on kidney development | Q41615287 | ||
Differentiation of breast cancer cells in vitro is promoted by the concurrent influence of myoepithelial cells and relaxin | Q41822058 | ||
Regulation of vimentin expression in cultured human mammary epithelial cells | Q41874497 | ||
Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells | Q42085277 | ||
Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells | Q42437094 | ||
Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, lactating, and involuting rat mammary gland | Q42448447 | ||
Expression of Cx26, Cx32 AND Cx43 gap junction proteins in normal and neoplastic human tissues | Q42451293 | ||
Myoepithelial markers are expressed in at least 29% of oestrogen receptor negative invasive breast carcinoma | Q42459925 | ||
Characterization of human mammary cell types in primary culture: immunofluorescent and immunocytochemical indicators of cellular heterogeneity | Q42496647 | ||
Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue | Q42509095 | ||
Gap junction distribution and connexin expression in human breast | Q42517878 | ||
Identification of myoepithelial cells in human and rat breasts by anti-common acute lymphoblastic leukemia antigen antibody A12. | Q43820381 | ||
Altered mammary epithelial development, pattern formation and involution in transgenic mice expressing the EphB4 receptor tyrosine kinase. | Q43860804 | ||
The human myoepithelial cell is a natural tumor suppressor | Q46183897 | ||
Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma | Q46247173 | ||
Characterizations of the extracellular matrix and proteinase inhibitor content of human myoepithelial tumors | Q46487412 | ||
The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis | Q46561125 | ||
Immunocytochemical identification of basic fibroblast growth factor in the developing rat mammary gland: variations in location are dependent on glandular structure and differentiation | Q52224968 | ||
Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. | Q53453015 | ||
The myoepithelium in human breast carcinoma. | Q54196206 | ||
Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. | Q54252495 | ||
[Cytokeratins as markers of differentiation. Expression profiles in epithelia and epithelial tumors] | Q54255575 | ||
Breast cell invasive potential relates to the myoepithelial phenotype. | Q54768849 | ||
Enhanced synthesis of gelatinase and stromelysin by myoepithelial cells during involution of the rat mammary gland | Q67487975 | ||
Localization of basic fibroblast growth factor and transforming growth factor beta 1 in the human mammary gland | Q67946428 | ||
Identification, paracrine generation, and possible function of human breast carcinoma myofibroblasts in culture | Q68121222 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 190-197 | |
P577 | publication date | 2005-07-12 | |
P1433 | published in | Breast Cancer Research | Q2208481 |
P1476 | title | Myoepithelial cells: good fences make good neighbors | |
P478 | volume | 7 |
Q58575428 | A METHOD FOR QUANTIFICATION OF CALPONIN EXPRESSION IN MYOEPITHELIAL CELLS IN IMMUNOHISTOCHEMICAL IMAGES OF DUCTAL CARCINOMA IN SITU |
Q90461821 | A Review on Mammary Tumors in Rabbits: Translation of Pathology into Medical Care |
Q35685928 | A block in lineage differentiation of immortal human mammary stem / progenitor cells by ectopically-expressed oncogenes |
Q33418745 | A compact VEGF signature associated with distant metastases and poor outcomes |
Q40285507 | A requirement for dimerization of HP1Hsalpha in suppression of breast cancer invasion. |
Q35128842 | A strategy for tissue self-organization that is robust to cellular heterogeneity and plasticity |
Q47131388 | Age-related gene expression in luminal epithelial cells is driven by a microenvironment made from myoepithelial cells |
Q37502195 | Alternative exon usage creates novel transcript variants of tumor suppressor SHREW-1 gene with differential tissue expression profile. |
Q36655984 | Alveolar and lactogenic differentiation |
Q27302977 | Asymmetric expression of connexins between luminal epithelial- and myoepithelial- cells is essential for contractile function of the mammary gland |
Q88945987 | Attenuation of Mammary Gland Dysplasia and Feeding Difficulties in Tabby Mice by Fetal Therapy |
Q33642033 | Biocompatible tissue scaffold compliance promotes salivary gland morphogenesis and differentiation |
Q47893420 | Bottom-up assembly of salivary gland microtissues for assessing myoepithelial cell function. |
Q36409895 | Cell polarity proteins: common targets for tumorigenic human viruses |
Q41251750 | Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia |
Q54704286 | Characterization of primary cilia distribution and morphology during lactation, stasis, and involution in the bovine mammary gland. |
Q33844032 | Context-Dependent Function of Myoepithelial Cells in Breast Morphogenesis and Neoplasia |
Q60585237 | Cx43 suppresses mammary tumor metastasis to the lung in a Cx43 mutant mouse model of human disease |
Q60957600 | Dachshund Depletion Disrupts Mammary Gland Development and Diverts the Composition of the Mammary Gland Progenitor Pool |
Q36245627 | Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer. |
Q28482309 | Derivation of myoepithelial progenitor cells from bipotent mammary stem/progenitor cells |
Q37795622 | Determinants of leader cells in collective cell migration |
Q90317070 | Development and characterization of mammary intraductal (MIND) spontaneous metastasis models for triple-negative breast cancer in syngeneic mice |
Q37316573 | Early dysregulation of cell adhesion and extracellular matrix pathways in breast cancer progression |
Q47939983 | Elucidating the Role of the Desmosome Protein p53 Apoptosis Effector Related to PMP-22 in Growth Hormone Tumors |
Q91863461 | Expression analysis of vimentin and the related lncRNA network in breast cancer |
Q35586530 | Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma |
Q90381708 | Expression of Myoepithelial Markers in Mammary Carcinomas of 119 Pet Rabbits |
Q36885727 | GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer. |
Q49712655 | Histochemical properties of bovine and ovine mammary glands during fetal development |
Q38908913 | Hypoxia-induced nitric oxide release by luminal cells stimulates proliferation and uPA secretion of myoepithelial cells in a bicellular murine mammary tumor. |
Q34977042 | Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease. |
Q33229887 | Interstitial Cajal-like cells (ICLC) in human resting mammary gland stroma. Transmission electron microscope (TEM) identification. |
Q37719854 | Invertebrate specific D1-like dopamine receptor in control of salivary glands in the black-legged tick Ixodes scapularis |
Q34781039 | Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer |
Q37390641 | LPA receptor activity is basal specific and coincident with early pregnancy and involution during mammary gland postnatal development |
Q52725291 | Laminin signals initiate the reciprocal loop that informs breast-specific gene expression and homeostasis by activating NO, p53 and microRNAs. |
Q37717525 | Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function |
Q35889581 | Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis |
Q90061176 | Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition |
Q54965481 | MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis. |
Q33761157 | Mapping mammary gland architecture using multi-scale in situ analysis |
Q36415307 | Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell |
Q33755906 | Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression? |
Q35877893 | Mechanobiology of tumor invasion: engineering meets oncology |
Q34444593 | Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer |
Q34418858 | Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes |
Q37756399 | Molecular biology of breast tumor progression: a view from the other side |
Q34205235 | Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer |
Q52938678 | Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid. |
Q64972123 | Myoepithelial cells are a dynamic barrier to epithelial dissemination. |
Q38660393 | Myoepithelial cells in canine mammary tumours |
Q31047373 | Myoepithelial cells in the control of mammary development and tumorigenesis: data from genetically modified mice |
Q33557658 | Myoepithelial cells: their origin and function in breast morphogenesis and neoplasia |
Q35518665 | Myosin II isoform switching mediates invasiveness after TGF-β-induced epithelial-mesenchymal transition |
Q40252191 | NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. |
Q42444859 | Na(+) /H(+) exchanger 1 (NHE1) function is necessary for maintaining mammary tissue architecture |
Q57489747 | Nanoscale Topography and Poroelastic Properties of Model Tissue Breast Gland Basement Membranes |
Q57158003 | Native-mimicking in vitro microenvironment: an elusive and seductive future for tumor modeling and tissue engineering |
Q47582792 | Nuclear inverse polarity papillary lesions lacking myoepithelial cells: A report of two cases |
Q47103096 | Obesity reversibly depletes the basal cell population and enhances mammary epithelial cell estrogen receptor alpha expression and progenitor activity |
Q30355361 | Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. |
Q33740398 | Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes |
Q39643653 | Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway |
Q36998060 | PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV. |
Q36787398 | PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes |
Q29994686 | Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ |
Q91714224 | Primary Mammary Organoid Model of Lactation and Involution |
Q24658369 | Quis custodiet ipsos custodies: who watches the watchmen? |
Q35071026 | Requirement of a myocardin-related transcription factor for development of mammary myoepithelial cells |
Q33995825 | Role of myoepithelial cells in breast tumor progression |
Q39855126 | Selective culture of different types of human parotid gland cells |
Q34526848 | Septic disruption of lactiferous ducts with heterogeneous carcinoma of the breast in a lactating woman |
Q37121476 | Stem cell research: a novel boulevard towards improved bovine mastitis management |
Q38015229 | Strategies for the discovery and development of therapies for metastatic breast cancer |
Q34552074 | Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer |
Q34069482 | Telomerase-immortalized human mammary stem/progenitor cells with ability to self-renew and differentiate |
Q30491017 | The MAPK(ERK-1,2) pathway integrates distinct and antagonistic signals from TGFalpha and FGF7 in morphogenesis of mouse mammary epithelium |
Q36717612 | The extracellular matrix as an adhesion checkpoint for mammary epithelial function |
Q39175548 | The molecular basis of breast cancer pathological phenotypes |
Q35745252 | The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers |
Q38964801 | The reciprocal association between mammographic breast density, hyaluronan synthesis and patient outcome |
Q36467412 | The severity of mammary gland developmental defects is linked to the overall functional status of Cx43 as revealed by genetically modified mice |
Q43121328 | The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin |
Q28285698 | Timing of dietary estrogenic exposures and breast cancer risk |
Q37805245 | Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy |
Q52725293 | Transient external force induces phenotypic reversion of malignant epithelial structures via nitric oxide signaling. |
Q34038325 | Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate? |
Q34078810 | Triennial Lactation Symposium: Bovine mammary epithelial cell lineages and parenchymal development |
Q51220674 | Tumors and tumor-like lesions in the mammary gland of 24 pet rabbits: a histomorphological and immunohistochemical characterization |
Q36078608 | Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion |
Q34452586 | Versican expression in canine carcinomas in benign mixed tumours: is there an association with clinical pathological factors, invasion and overall survival? |
Q35984566 | Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas |
Q82349555 | WT1 expression in salivary gland pleomorphic adenomas: a reliable marker of the neoplastic myoepithelium |
Q37024021 | beta1 integrin as a molecular therapeutic target. |
Search more.